InMed’s President and CEO, Eric A. Adams, and Senior VP, Preclinical Research and Development, Dr. Eric Hsu, talks about “Exploring the Neuroprotective Qualities of Rare Cannabinoids.” This webinar was hosted by John Heerdink of The Tribe Public on November 17, 2022.
In the webinar, the InMed team talks about the company’s recent research demonstrating the neuroprotective effects and enhanced neuronal function of specific rare cannabinoids. They share some of the research and data and talk of two cannabinoid analog compounds which showed stronger effects than other cannabinoids tested. InMed has selected to advance these two cannabinoid analogs to in vivo studies of neurodegenerative disease.
